Literature DB >> 12580758

Putative functional characteristics of human estrogen receptor-beta isoforms.

B Peng1, B Lu, E Leygue, L C Murphy.   

Abstract

Estrogen receptors (ERalpha and ERbeta) are clearly multifaceted in terms of structure and function. Several relatively abundant ERbeta isoforms have been identified, which can be differentially expressed in various tIssues. In order to provide insight into the possible role of the ERbeta family in breast tIssue a study of the putative functions of the human (h) ERbeta1, hERbeta2 and hERbeta5 isoforms was undertaken. Only hERbeta1 was found to bind ligand, which induced conformational changes as determined by protease digestion assays. All ERbeta isoforms could bind to and bend DNA although the relative efficiency with which they bound DNA differed with hERalpha>hERbeta1>hERbeta2>>hERbeta5. All ERbeta isoforms inhibited ERalpha transcriptional activity on an estrogen-response element (ERE)-reporter gene. The relative activities were hERbeta1>hERbeta2>hERbeta5; however, only hERbeta1 had transcriptional activity of its own. Both LY117018-hERalpha and LY117018-hERbeta1 complexes alone could activate transcription on a TGF-beta3-CAT gene. Although hERbeta2 and hERbeta5 had no activity alone, they inhibited ERalpha but not hERbeta1 transcriptional activity of transforming growth factor (TGF)-beta3-CAT. In marked contrast to activity on an ERE-CAT reporter gene, hERbeta1 did not modulate ERalpha transcriptional activity on a TGF-beta3-CAT reporter gene. These data support promoter-specific differential activities of hERbeta isoforms with respect to models of ERalpha regulated gene expression, and suggest that they may have a role in differentially modulating estrogen action.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12580758     DOI: 10.1677/jme.0.0300013

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  49 in total

1.  Differential role of estrogen receptor beta in early versus metastatic non-small cell lung cancer.

Authors:  Sri Navaratnam; Georgios Skliris; Gefei Qing; Shantanu Banerji; Ketan Badiani; Dongsheng Tu; Penelope A Bradbury; Natasha B Leighl; Frances A Shepherd; Janet Nowatzki; Alain Demers; Leigh Murphy
Journal:  Horm Cancer       Date:  2012-06       Impact factor: 3.869

2.  Estrogen receptors inhibit Smad3 transcriptional activity through Ap-1 transcription factors.

Authors:  Tracy Cherlet; Leigh C Murphy
Journal:  Mol Cell Biochem       Date:  2007-07-28       Impact factor: 3.396

3.  Estrogen receptor β2 is inversely correlated with Ki-67 in hyperplastic and noninvasive neoplastic breast lesions.

Authors:  Nuiki Iota Chantzi; Marina Palaiologou; Artemis Stylianidou; Nikos Goutas; Stamatis Vassilaros; Helen P Kourea; Eugen Dhimolea; Dimitra J Mitsiou; Dina G Tiniakos; Muichael N Alexis
Journal:  J Cancer Res Clin Oncol       Date:  2014-03-27       Impact factor: 4.553

4.  Estrogen receptor (ER)-beta isoforms: a key to understanding ER-beta signaling.

Authors:  Yuet-Kin Leung; Paul Mak; Sazzad Hassan; Shuk-Mei Ho
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-22       Impact factor: 11.205

Review 5.  Structural and functional characteristics of oestrogen receptor β splice variants: Implications for the ageing brain.

Authors:  C K Kim; A Torcaso; A Asimes; W C J Chung; T R Pak
Journal:  J Neuroendocrinol       Date:  2018-02       Impact factor: 3.627

Review 6.  Steroid hormone receptors as prognostic markers in breast cancer.

Authors:  Maggie C Louie; Mary B Sevigny
Journal:  Am J Cancer Res       Date:  2017-08-01       Impact factor: 6.166

7.  Estrogen receptor-alpha overexpression suppresses 17beta-estradiol-mediated vascular endothelial growth factor expression and activation of survival kinases.

Authors:  Shameena Bake; Lijiang Ma; Farida Sohrabji
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

8.  Estrogen receptor beta2 and beta5 are associated with poor prognosis in prostate cancer, and promote cancer cell migration and invasion.

Authors:  Yuet-Kin Leung; Hung-Ming Lam; Shulin Wu; Dan Song; Linda Levin; Liang Cheng; Chin-Lee Wu; Shuk-Mei Ho
Journal:  Endocr Relat Cancer       Date:  2010-06-25       Impact factor: 5.678

9.  Estrogen signaling in colorectal carcinoma microenvironment: expression of ERbeta1, AIB-1, and TIF-2 is upregulated in cancer-associated myofibroblasts and correlates with disease progression.

Authors:  Vassiliki Tzelepi; Petros Grivas; Zinovia Kefalopoulou; Haralabos Kalofonos; John N Varakis; Maria Melachrinou; Georgia Sotiropoulou-Bonikou
Journal:  Virchows Arch       Date:  2009-03-07       Impact factor: 4.064

10.  Prognostic significance of full-length estrogen receptor beta expression in stage I-III triple negative breast cancer.

Authors:  Erin K Shanle; Adedayo A Onitilo; Wei Huang; KyungMann Kim; Chong Zang; Jessica M Engel; Wei Xu; Kari B Wisinski
Journal:  Am J Transl Res       Date:  2015-07-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.